Regulatory Examination Finding Count

Goal of the analysis:

The objective is to quantify, trend, and segment the number of findings arising from regulatory examinations (e.g., MRAs/MRIAs, supervisory observations, consent-order items). This analysis helps executives assess the health of the control environment, readiness for supervisory scrutiny, and operational discipline in issue management. It informs risk appetite setting, remediation prioritization, budgeting, and regulatory engagement strategy. A clear view of counts, severity mix, backlog, aging, and repeat findings enables boards, CROs, and CAEs to mitigate enforcement risk, reduce remediation cost, and protect franchise value.

Data required:

• Examination inventory and context:
  • Exam ID, regulator/authority (e.g., OCC, CFPB, FCA, EPA, FDA), legal entity, business/unit, geography.
  • Exam type (safety and soundness, consumer compliance, AML, cybersecurity, health/safety, environmental), scope, start/end dates, intensity (days onsite).
  • Exam outcome summaries, ratings, supervisory letters, enforcement status (if any).
• Finding metadata:
  • Finding/issue ID, title, description, severity (e.g., MRIA/MRA/High/Moderate/Low), priority, risk domain and regulation reference.
  • Root cause category (policy, process, people, data, tech, third party, change management), control mapping (control IDs, process).
  • Dates: issue issued, target remediation, extensions, closure, validation/re-open date; current status; repeat/re-open flags.
• Remediation plans and validation:
  • Action plans, milestones, accountable owner, budget, dependencies, evidence artifacts, validation/test results (2LOD/3LOD/regulator).
  • Past-due indicators, number of extension requests, sustainability actions (procedures, training, monitoring).
• Reference and normalization data:
  • Control inventory and RCSA ratings, incident/loss events, change portfolio (projects/releases), staffing and vacancy rates.
  • Scale denominators: assets/revenue, customer accounts, transactions, number of controls/processes, headcount.
  • Benchmarks: prior exam cycles, peer insights (if legally shareable), internal targets/thresholds.
• Systems/sources: GRC platforms (e.g., Archer, ServiceNow GRC, MetricStream), exam management trackers, issue management systems, document repositories, data warehouse.

Detailed step-by-step instruction on how to conduct the analysis:

1. Scope and extract: Define the analysis period (e.g., last 8 quarters) and population (all regulators, all legal entities). Extract exam inventory and findings from the GRC system. Include status history to compute age and past-due metrics. Pull scale denominators (assets, headcount, controls) for normalization.
2. Standardize taxonomy and cleanse:
   • Map all severity labels to a common scale (e.g., MRIA=Critical, MRA=High, Moderate, Low). Align status values (Open, Past Due, In Validation, Closed, Re-opened).
   • Deduplicate findings (merge duplicates across systems) and link to parent exam. Tag “repeat” if substantially the same root cause/control is cited within a defined lookback (e.g., 24–36 months).
   • Normalize root cause categories and risk domains; verify regulator identifiers and legal entity mappings.
3. Define counting rules:
   • Decide whether to count “issues” at the parent level or include “sub-issues/recommendations.” Use one level consistently.
   • Define inclusion (regulator-issued findings) and exclusion (informal management comments) criteria.
   • Set measurement basis: counts “issued in period,” “closed in period,” and “open backlog at period end.”
   • Create a severity-weighted index: e.g., MRIA=5, MRA=3, Moderate=2, Low=1 to reflect risk intensity.
4. Compute core metrics:
   • Total findings issued; counts by severity; severity-weighted index.
   • Open backlog; past-due open; reopened count; repeat finding count and rate.
   • Closure velocity: closures per month; median days to closure; % meeting target date; extension request rate.
   • Normalized metrics: findings per $1B assets/revenue, per 100 controls, per 1,000 employees, per exam.
5. Segment and compare:
   • By regulator, legal entity, business unit, region, product, exam type, risk domain, and root cause.
   • Compare current period vs prior periods; compute deltas and control for exam volume/intensity.
   • Identify concentration: top 10 entities/units contributing to 80% of severe findings (Pareto).
6. Trend and context:
   • Quarterly time series for counts and severity index; overlay exam count to adjust interpretation.
   • Backlog aging buckets (0–90, 91–180, 181–365, 365+ days); track re-open and repeat rates over time.
   • Correlate with RCSA residual risk, audit ratings, operational incidents, and change activity.
7. Validate and reconcile: Tie totals to exam letters and issue registers; sample-check metadata (severity, dates). Obtain sign-off from Exam Management Office and Issue Management.
8. Synthesize insights: Identify systemic root causes, high-risk domains, capacity constraints, and remediation bottlenecks. Formulate prioritized actions with owners and timelines.

Format of the output of analysis:

• Executive scorecard summarizing total findings, severity mix, backlog, past-due, repeat, reopened, and closure velocity.
• Time-series charts for counts and severity-weighted index, with exam volume overlays.
• Heatmaps by regulator, business unit, legal entity, and risk domain; Pareto charts of top contributors.
• Aging distributions, waterfall of backlog (opening + new − closed = ending), and normalization views (per $1B assets, per 100 controls).
• Root cause breakdown and linkage to RCSA ratings and audit outcomes.
• Appendix: methodology, counting rules, data quality notes, and reconciliation to official registers.

How to interpret results:

• High total/severity-weighted counts: Signal control weaknesses, regulatory exposure, and potential for heightened supervisory actions. If concentrated in a few units, target those for deep remediation.
• Low counts: May reflect strong controls or limited exam intensity; cross-check against exam coverage and quality of self-identification to avoid false comfort.
• Backlog and aging: High past-due and long aging indicate execution gaps, resourcing constraints, or over-complex remediation. Rising re-open rates suggest inadequate validation or non-sustainable fixes.
• Severity mix: A small number of high-severity (MRIA/MRA) findings can be more concerning than many low-level items. Track the severity-weighted index alongside raw counts.
• Segment differences: Variance by regulator or domain highlights divergent standards or weak spots (e.g., AML, model risk, product compliance). Persistent repeats point to root-cause misdiagnosis.
• Trends and benchmarks: Improving trends are visible when counts and severity index decline while exam volume is stable and closure velocity improves. Benchmark gaps guide investment and staffing decisions.

Steps a company can take to improve on this measure:

• Process and governance:
  • Strengthen issue lifecycle governance: clear ownership, milestone gates, and sustainability checks before closure.
  • Institute exam readiness playbooks, mock exams, and pre-issuance challenge of draft findings.
  • Embed root-cause analysis standards (5-Whys, fishbone) and require control design remediation, not just procedural fixes.
  • Implement change controls and break-glass processes to reduce operational errors during major releases.
• Data, systems, and tooling:
  • Enhance the GRC platform: taxonomy harmonization, deduplication logic, automated alerts, and SLA tracking.
  • Link controls to regulatory obligations; maintain an evidence library to support validation and sustainability.
  • Deploy dashboards and KRIs (e.g., repeat rate, past-due %) for leadership and board oversight.
• Capability building and culture:
  • Train first-line owners on regulatory expectations, documentation, and testing standards.
  • Establish a central Exam Management Office and Regulatory Liaison to coordinate responses and consistency.
  • Reinforce accountability through performance goals and incentives tied to timely, sustainable remediation.
• Targeted control and product changes:
  • Automate high-error, manual processes; standardize procedures across entities; reduce exceptions.
  • Rationalize products and third parties that disproportionately drive findings; invest in high-risk domains (e.g., AML/KYC, data quality, cyber).
  • If high total but low severity, focus on documentation/recordkeeping improvements; if low total but high severity, prioritize end-to-end control redesign and independent challenge.

Benchmark comparisons:

General benchmarks:

• External benchmarks vary widely by sector, regulator, and exam intensity. Indicatively, large, highly regulated financial institutions may see dozens to low hundreds of findings annually across all regulators; top performers keep high-severity items to low single digits and repeat rates below 10%.
• Median closure times often range 120–270 days for moderate findings and longer for MRAs/MRIAs; top-quartile organizations achieve >85% on-time closure and <5% past due beyond 90 days.
• Severity-weighted indices should trend downward over time when controls strengthen, even if raw counts fluctuate with exam cadence.

Segment- or industry-specific benchmarks:

• Financial services: annual MRA counts per large entity frequently in the 5–30 range; MRIAs are uncommon (0–5). AML and model risk domains often drive severe items.
• Healthcare/pharma: FDA/quality observations can cluster around documentation and process validation; emphasis on sustainability and CAPA effectiveness.
• Energy/industrial: Safety/environmental agencies may drive fewer but severe findings tied to process safety and environmental controls.
• If robust external data are unavailable, construct internal benchmarks:
  • Trend over 8–12 quarters; compare units/entities normalized per $1B revenue/assets, per 100 controls, or per 1,000 employees.
  • Set internal top-quartile targets (e.g., repeat rate <10%, past due >90 days <5%, on-time closure >85%).
  • Calibrate thresholds to exam volume and mix to ensure apples-to-apples comparisons.